ABOUT US
Creating Exponential Learning and Growth
Creating Exponential Learning and Growth
ENTERPRISE · ACADEMIA
INTEGRATED
IMNEWRUN has formed a strategic alliance with Sungkyunkwan University (SKKU) and YUHAN Corporation to establish a vibrant neuroscience ecosystem within the university campus. Located at the N Center, a state-of-the-art neuroimaging facility, IMNEWRUN plays a central role as a dynamic learning platform, fostering innovation.
As part of this initiative, a new cryo-electro microscopic facility and a cutting-edge supercomputing center have been established. Additionally, construction is underway for an innovative research complex (CNS Center), which will serve as the future headquarters for IMNEWRUN.
Combining the power of AI, structural biology, and neuroimaging to develop next-generation treatment modalities.
LEADERSHIP
Han-Joo Kim
Chief Executive Officer
Hyouna Yoo
VP, Translation Science
Jinsun Kim
VP, Bioprocess Development
Un Na
VP, Platform Development
Yong-il An
VP, IP & Corp. Management
Minah Suh
VP, Advisor
Professor, SKKU
Yong Ho Kim
VP, Advisor
Associate Professor, SKKU
Jaecheol Lee
VP, Advisor
Associate Professor, SKKU
Han-Joo Kim
Chair of the board
IMNEWRUN Inc.
Minah Suh
Vice President
IMNEWRUN Inc.
Yong Ho Kim
Vice President
IMNEWRUN Inc.
Jung Min Jo
Auditor
IMNEWRUN Inc.
Young-Mi Lee -
Executive Vice Presidnet
YUHAN Corp.
BOARD OF DIRECTORS
ADVISORY BOARD
William F. Degrado
Professor, UCSF
Michael Mark
Former SVP, Boehringer Ingelheim
Carlo Condello
Associate Professor, UCSF
Young G. Shin
Professor, CNU
SangSeob Lee
Professor, SKKU
Yeup Yoon
Director, SAIHST, SKKU
COPORATE IDENTITY
BOW TO TOMORROW®
IMNEWRUN's CI is based on the motif of a 'bow' and is symbolized to represent a 'human face' in the middle. IMNEWRUN's BOW TO TOMORROW represents the company's vision of flying with impact, reaching the target of the disease with precision, delivering hope for life through intensive treatment, putting the value of life first, and benefiting the world.
BOW TO TOMORROW®
